Company Filing History:
Years Active: 2009
Title: Nadine Mothes: Innovator in Hypoallergenic Antigen Development
Introduction
Nadine Mothes is a prominent inventor based in Sollenau, Austria. She has made significant contributions to the field of allergen research, particularly in the development of hypoallergenic mosaic antigens. Her innovative approach aims to improve the safety and efficacy of allergen immunotherapy.
Latest Patents
Nadine Mothes holds a patent for a process titled "Process for the preparation of hypoallergenic mosaic antigens." This patent describes a method where an allergen is split into at least two parts, and the IgE reactivity of each part is determined. The process then combines those parts of the allergen that show no detectable IgE reaction into a mosaic antigen. This mosaic antigen retains the amino acids of the original allergen but alters their order, enhancing its hypoallergenic properties. She has 1 patent to her name.
Career Highlights
Nadine Mothes is associated with Biomay AG, a company known for its advancements in biopharmaceuticals. Her work at Biomay AG has positioned her as a key player in the development of innovative solutions for allergy treatment.
Collaborations
Nadine collaborates with talented professionals in her field, including Sabine Stumvoll and Margit Focke. Their combined expertise contributes to the ongoing research and development of hypoallergenic products.
Conclusion
Nadine Mothes is a trailblazer in the field of hypoallergenic antigen development, with her innovative patent paving the way for safer allergy treatments. Her contributions to Biomay AG and collaborations with esteemed colleagues further enhance her impact in the scientific community.